Copyright
©The Author(s) 2004.
World J Gastroenterol. Jun 1, 2004; 10(11): 1656-1658
Published online Jun 1, 2004. doi: 10.3748/wjg.v10.i11.1656
Published online Jun 1, 2004. doi: 10.3748/wjg.v10.i11.1656
Table 1 Demographic features of study population
| OAC | LAC | PAC | P | |
| Patient number | 49 | 46 | 44 | NS |
| Female/Male | 26/23 | 23/23 | 24/20 | NS |
| Year | ||||
| Mean | 47.5 ± 13.4 | 45.7 ± 12.5 | 44.5 ± 13.5 | NS |
| Range | 20-75 | 21-73 | 20-70 | NS |
| Smoking | 7 (14.2%) | 6 (13%) | 6 (13.6%) | NS |
| NSAID | 9 (18.3%) | 8 (17.3%) | 8 (17.1%) | NS |
| Alcohol | (22.4%) | 9 (19.5%) | 10 (22.7%) | NS |
Table 2 Endoscopic findings
| Finding | Patient n, (%) |
| Antral gastritis | 62 (44.5) |
| Pangastritis | 34 (24.5) |
| Bulbitis | 14 (10) |
| Bile reflux gastritis | 12 (8.6) |
| Duodenal ulcer | 7 (5.3) |
| Atrophic gastritis | 6 (4.3) |
| Gastric ulcer | 4 (2.8) |
-
Citation: Altintas E, Sezgin O, Ulu O, Aydin O, Camdeviren H. Maastricht II treatment scheme and efficacy of different proton pump inhibitors in eradicating
Helicobacter pylori . World J Gastroenterol 2004; 10(11): 1656-1658 - URL: https://www.wjgnet.com/1007-9327/full/v10/i11/1656.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i11.1656